A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
暂无分享,去创建一个
D. Esseltine | L. Carey | A. Ivanova | E. Dees | R. Orlowski | C. Lindley | F. Collichio | B. O'Neil | J. Collins | W. Riordan